Your browser doesn't support javascript.
Efficacy of Antibodies and Antiviral Drugs against Omicron BA.2.12.1, BA.4, and BA.5 Subvariants.
Takashita, Emi; Yamayoshi, Seiya; Simon, Viviana; van Bakel, Harm; Sordillo, Emilia M; Pekosz, Andrew; Fukushi, Shuetsu; Suzuki, Tadaki; Maeda, Ken; Halfmann, Peter; Sakai-Tagawa, Yuko; Ito, Mutsumi; Watanabe, Shinji; Imai, Masaki; Hasegawa, Hideki; Kawaoka, Yoshihiro.
  • Takashita E; National Institute of Infectious Diseases, Tokyo, Japan.
  • Yamayoshi S; University of Tokyo, Tokyo, Japan.
  • Simon V; Icahn School of Medicine at Mount Sinai, New York, NY.
  • van Bakel H; Icahn School of Medicine at Mount Sinai, New York, NY.
  • Sordillo EM; Icahn School of Medicine at Mount Sinai, New York, NY.
  • Pekosz A; Johns Hopkins University, Baltimore, MD.
  • Fukushi S; National Institute of Infectious Diseases, Tokyo, Japan.
  • Suzuki T; National Institute of Infectious Diseases, Tokyo, Japan.
  • Maeda K; National Institute of Infectious Diseases, Tokyo, Japan.
  • Halfmann P; University of Wisconsin-Madison, Madison, WI.
  • Sakai-Tagawa Y; University of Tokyo, Tokyo, Japan.
  • Ito M; University of Tokyo, Tokyo, Japan.
  • Watanabe S; National Institute of Infectious Diseases, Tokyo, Japan.
  • Imai M; University of Tokyo, Tokyo, Japan.
  • Hasegawa H; National Institute of Infectious Diseases, Tokyo, Japan.
  • Kawaoka Y; University of Tokyo, Tokyo, Japan yoshihiro.kawaoka@wisc.edu.
N Engl J Med ; 387(5): 468-470, 2022 08 04.
Article in English | MEDLINE | ID: covidwho-1940462

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Antibodies, Neutralizing / SARS-CoV-2 / COVID-19 / COVID-19 Drug Treatment / Immunologic Factors / Antibodies, Monoclonal Topics: Vaccines / Variants Limits: Humans Language: English Journal: N Engl J Med Year: 2022 Document Type: Article Affiliation country: NEJMc2207519

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Antibodies, Neutralizing / SARS-CoV-2 / COVID-19 / COVID-19 Drug Treatment / Immunologic Factors / Antibodies, Monoclonal Topics: Vaccines / Variants Limits: Humans Language: English Journal: N Engl J Med Year: 2022 Document Type: Article Affiliation country: NEJMc2207519